GHC
PFE icon

Great Hill Capital’s Pfizer PFE Stock Holding History

Great Hill Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1M Buy
1,055,400
+168,700
+19% +$4.41M 0.49% 8
2026
Q1 		$23.9M Buy
886,700
+248,400
+39% +$6.61M 1.56% 4
2025
Q4 		$12.1M Buy
+638,300
New +$16.1M 1.2% 11

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Great Hill Capital's PFE Position: Q2 2026 in Review

Great Hill Capital reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $57.5K and leaving 12,572 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #44.

Great Hill Capital first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $415K in Q1 2026. 938 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Great Hill Capital held 12,572 shares of Pfizer worth $303K as of Q2 2026.
  • Great Hill Capital sold 2,200 Pfizer shares in Q2 2026, an estimated $57.5K.
  • Pfizer made up 0.01% of Great Hill Capital's portfolio in Q2 2026, its #44 holding.
  • Great Hill Capital first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Great Hill Capital's Pfizer position peaked at $415K in Q1 2026.
  • 938 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Great Hill Capital's 13F filing for Q2 2026, filed 27 Jul 2026.